In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  pegaspargase
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Behavioral study, Treatment
Status: Active
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: NCI-2009-00307, CDR0000514500, COG-AALL0434, AALL0434, U10CA098543, NCT00408005

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 35 to 70
Sponsor: NCI
Protocol IDs: NCI-2013-02229, ECOG-E1910, E1910, U10CA021115, U10CA180820, NCT02003222

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: NKT-SYSUCC-2013, NCT02085655

4.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 1 to 30
Sponsor: NCI
Protocol IDs: NCI-2014-00631, COG-AALL1331, AALL1331, U10CA098543, U10CA180886, NCT02101853

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 365 days to 18 years
Sponsor: NCI, Other
Protocol IDs: 11-001, NCT01574274

6.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: PALG ALL6, NCT01665001

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: LMTG 12-02, NCT01667302

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: ALLR18, NCT01700946

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: HEMALL0008, NCI-2012-03094, NCT01769209

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: 12-266, NCT01920737

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: B2013-017-01, NCT01921790

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 15 to 60
Sponsor: Other
Protocol IDs: MESA-NKT2013, NCT01933282

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: B2013-030-01, NCT01991158

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: 130934, NCT02043587

15.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 65
Sponsor: Other
Protocol IDs: LAL1913, NCT02067143

16.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 69
Sponsor: Other
Protocol IDs: GELOX1, NCT02080234

17.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PRO00020384, NCT01887587

18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 30 and under
Sponsor: Other
Protocol IDs: SIR-MO-1101, 2012-0361, NCT01658007

19.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 13-165, NCT01878708

20.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: ALL-MB 2008, NCT01953770
New Search